INSIGHTS ON DRUG DEVELOPMENT
-
Optimize Your mAb Capture And Polishing With The Latest Resins And Tips
Discover the latest innovations in monoclonal antibody purification and explore resin selection strategies to optimize product quality and improve process efficiency.
-
Ready To Demystify Organoids?
Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.
-
Studying The Spatial Architecture Of Glioblastoma
Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
-
An All-In-One Solution For Residual DNA Quantitation
Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
-
Improving Swallowing And Palatability With Patient‑Friendly Forms1/15/2026
Improve medication adherence and health outcomes by developing patient-friendly dosage forms that enhance swallowability and palatability for pediatric, geriatric, and dysphagic populations.
-
Predicting Hepatotoxicity With The Liver-Chip8/2/2024
Enhance your understanding of liver organoids and their pivotal role in enhancing DILI risk prediction through the use of advanced Organ-Chip technology.
-
Thunderstruck By Antibody-Drug Conjugates3/18/2025
Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.
-
Patented Process For Olopatadine HCl API Intermediates7/15/2026
See how this patented Wittig-based process for olopatadine HCl achieves Z/E isomer ratios up to 4:1, eliminating dangerous reagents like n-butyl lithium while cutting purification complexity.
-
Predicting Performance Of Lotions Through Rheological Characterization5/6/2026
Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.
DRUG DEVELOPMENT SOLUTIONS
-
Power. Potential. Productivity.
STELLARIS 5 is a completely re-imagined confocal microscope platform.
STELLARIS confocal microscopes can be combined with all Leica modalities, including FLIM, STED, DLS, and CRS. With the STELLARIS confocal platform, we have re-imagined confocal microscopy to get you closer to the truth.
- Power to see more
- Potential to discover more
- Productivity to do more
-
Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.
-
Malvern 2000 Laser Diffraction Particle Size Analyzer with (1) Malvern Model Scirocco 2000, Dry Power Tray Sampler, and (1) Malvern Model Hydro 2000S, Liquid Test Module.
-
Leica DM3000
Enhance Laboratory Workflow
The Leica DM3000 microscopes for pathology, cytology, haematology and many other applications feature a motorized nosepiece, condenser head, automated light intensity adjustment, and optional foot pedal. These intuitive microscopes improve workflows significantly. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
With extensive experience in handling challenging chemistries and complex synthetic processes, we deliver tailored solutions designed to support successful progression from preclinical studies to market.